AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Quest Diagnosis offers gene-based cancer tests for bladder and breast cancer.(Brief Article)
2002 JUN 6 - (NewsRx.com & NewsRx.net) -- Quest Diagnostics, Inc., (DGX) has begun offering Abbott Laboratories' Vysis UroVysion DNA Probe Assay, a noninvasive method for monitoring the recurrence of bladder cancer in patients previously diagnosed with the disease.
In March 2002, the U.S. Food and Drug Administration (FDA) cleared Abbott Laboratories' use of new clinical data in the test's labeling as providing further evidence of the test's effectiveness in monitoring bladder cancer recurrence.
UroVysion can be used in conjunction with cystoscopy and is the only DNA-based test currently available for monitoring the recurrence of bladder cancer. The UroVysion assay is both highly sensitive and highly specific and, in many cases, can detect the presence of cancer cells in urine before a cancerous growth can be detected through cystoscopic visual inspection or urine cytology.
The test is based on fluorescence in situ hybridization (FISH) technology, which is able to detect genetic changes in tumor specimens with a high degree of accuracy. In contrast to other methods for ...
- Abbott Laboratories completes CE Mark process under IVD Directive for...
- Press release article from: PR Newswire September 29, 2003 700+ words
...with metastatic breast cancer Abbott Laboratories announced today...with metastatic breast cancer, has been CE...for women with breast cancer," said Edward...Diagnostics, Abbott Laboratories. "The CE mark...
- Abbott lab test helps breast cancer patients. (Abbott Laboratories, Diagnostics...
- Newspaper article from: Health Industry Today January 1, 1991 700+ words
Abbott lab test helps breast cancer patients The Diagnostics Division of Abbott Laboratories, Abbott Park, Ill., will market the company's new diagnostic test for managing breast cancer patients to hospital and reference labs and...
- Breast cancer test approved. (New Tests).(Abbott Laboratories)(Brief Article)
- Magazine article from: Medical Laboratory Observer May 1, 2002 700+ words
Abbott Laboratories, Abbott Park, IL...HER-2/neu gene in breast cancer patients for use in...women with metastatic breast cancer who could benefit from...positive metastatic breast cancer, an especially aggressive...
- Abbott Laboratories (Abbott Park, Illinois) said it anticipates that more...
- Newspaper article from: Diagnostics & Imaging Week September 19, 2002 700+ words
* Abbott Laboratories (Abbott Park, Illinois...anticipates that more breast cancer patients will benefit...women with metastatic breast cancer. Abbott said PathVysion...in 25% to 30% of breast cancer patients. Women with...
- Europroteome AG, of Berlin, extended its research collaboration with Abbott...
- Newspaper article from: BioWorld International July 21, 2004 700+ words
...research collaboration with Abbott Laboratories, of Abbott Park, Ill., for the discovery and development of breast cancer diagnostic tests upon successfully...serum samples from women with breast cancer. Data are aligned with a panel...
- Abbott Laboratories (Abbott Park, Illinois) received FDA approval for its Vysis...
- Newspaper article from: The BBI Newsletter February 1, 2002 700+ words
* Abbott Laboratories (Abbott Park, Illinois...HER-2/neu gene in breast cancer patients for use in...women with metastatic breast cancer who could benefit from...positive metastatic breast cancer. A diagnostic test...
- New findings published on treatment for late-stage breast cancer.
- Newspaper article from: Genomics & Genetics Weekly April 23, 2004 700+ words
...diagnosed with metastatic breast cancer. To determine the cost...research and development, Abbott Laboratories. "Personalized medicine...specifically in the fight against breast cancer." Abbott Laboratories' molecular diagnostics...
- Abbott Laboratories Announces Intent to Submit New Drug Application for...
- Press release article from: PR Newswire July 9, 2004 700+ words
...cell lung cancers. About Abbott Laboratories Abbott Laboratories is committed to the discovery...treatment benefit in women with breast cancer. Abbott also markets nutritional...needs of cancer patients. Abbott Laboratories is a global, broad-based...
- Abbott Laboratories' Investigational Angiogenesis Inhibitor Shows Activity And...
- Press release article from: PR Newswire June 3, 2003 700+ words
...development at Abbott Laboratories. Phase 2 studies...Oncology Franchise Abbott Laboratories is committed to...benefit in women with breast cancer. Abbott also markets...cancer patients. Abbott Laboratories is a global, broad...
- FDA Approves Inclusion of Abbott's PathVysion(R) Gene Test in Herceptin(R)...
- Press release article from: PR Newswire September 12, 2002 700+ words
...Ill. -- Abbott Laboratories anticipates that more breast cancer patients will...for women with breast cancer," said Edward...Operations, Abbott Laboratories. "Currently...testing for breast cancer. With the new...
Source: HighBeam Research, Quest Diagnosis offers gene-based cancer tests for bladder and breast...